Processes for the preparation of ortho-allylated hydroxy aryl compounds

US11795127B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11795127-B2
Application numberUS-202217964347-A
CountryUS
Kind codeB2
Filing dateOct 12, 2022
Priority dateMay 29, 2020
Publication dateOct 24, 2023
Grant dateOct 24, 2023

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present application describes process for preparing an ortho-allylated hydroxy aryl compounds such as compounds of Formula (I) by reacting an allylic alcohol with a hydroxy aryl compound in the presence of aluminum compound selected from alumina and aluminum alkoxides and in a non-protic solvent wherein at least one carbon atom ortho to the hydroxy group in the hydroxy aryl compound is unsubstituted. The present application also includes compounds of Formula (I).

First claim

Opening claim text (preview).

The invention claimed is: 1. A process for preparing a compound of Formula (I) comprising: reacting a compound of Formula (II) with a compound of Formula (III) in the presence of an aluminum compound selected from alumina and aluminum alkoxides and in a non-protic solvent to form the compound of Formula (I), wherein: n is 2, 3 or 4; two R 1 groups are linked together to form a polycyclic ring system having 8 or more atoms together with the phenyl ring to which said groups are bonded, and in which one or more carbon atoms in said polycyclic ring system is optionally replaced with a heteromoiety selected from NR 6 , O and S, wherein the polycyclic ring system is optionally substituted with one or more substituents selected from ═O, OH, halo, C 1-16 alkyl, C 2-16 alkenyl, C 2-16 alkynyl, OC 1-16 alkyl, OC 2-16 alkenyl, OC 2-16 alkynyl; C 1-16 alkyleneOR 8 , C 2-16 alkenyleneOR 8 , C 2-16 alkynyleneOR 8 , C 6-18 aryl, C 3-18 cycloalkyl, C 3-18 heterocycloalkyl, and C 5-18 heteroaryl, the latter 4 groups being optionally substituted with one or more substituents selected from OH, halo, C 1-16 alkyl, OC 1-16 alkyl, and C 2-16 alkenyl; when n is 3 or 4, further R 1 groups are independently selected from OH, halo, CN, NO 2 , COOH, C 2-16 alkenyl, C 2-16 alkynyl, C 3-18 cycloalkyl, C 1-16 alkyleneC 3-18 cycloalkyl, C 2-16 alkenyleneC 3-18 cycloalkyl, C 2-16 alkynyleneC 3-18 cycloalkyl, C 3-18 heterocycloalkyl, C 1-16 alkyleneC 3-18 heterocycloalkyl, C 1-10 alkenyleneC 3-18 heterocycloalkyl, C 2-16 alkynyleneC 3-18 heterocycloalkyl, C 6-18 aryl, C 1-16 alkyleneC 6-18 aryl, C 2-16 alkenyleneC 6-18 aryl, C 2-16 alkynyleneC 6-18 aryl, C 5-18 heteroaryl, C 2-16 alkyleneC 5-18 heteroaryl, C 2-16 alkenyleneC 5-18 heteroaryl, C 2-16 alkynyleneC 5-18 heteroaryl, Z—C 2-16 alkenyl, Z—C 2-16 alkynyl, Z—C 3-18 cycloalkyl, Z—C 1-16 alkyleneC 3-18 cycloalkyl, Z—C 2-16 alkenyleneC 3-18 cycloalkyl, Z—C 2-16 alkynyleneC 3-18 cycloalkyl, Z—C 3-18 heterocycloalkyl, Z—C 1-16 alkyleneC 3-18 heterocycloalkyl, Z—C 2-16 alkenyleneC 3-18 heterocycloalkyl, Z—C 2-16 alkynyleneC 3-18 heterocycloalkyl, Z—C 6-18 aryl, Z—C 1-16 alkyleneC 6-18 aryl, Z—C 2-16 alkenyleneC 6-18 aryl, Z—C 2-16 alkynyleneC 6-18 aryl, Z—C 5-18 heteroaryl, Z—C 1-16 alkyleneC 5-18 heteroaryl, Z—C 2-16 alkenyleneC 5-18 heteroaryl, and Z—C 2-16 alkynyleneC 5-18 heteroaryl, wherein all alkyl, alkenyl, alkynyl, alkylene, alkenylene, alkynylene, cycloalkyl heterocycloalkyl, aryl, and heteroaryl groups are optionally substituted with one or more substituents selected from OH, halo, C 1-16 alkyl, C 2-16 alkenyl, C 2-6 alkynyl, OC 1-16 alkyl, OC 2-16 alkenyl, and OC 2-16 alkynyl; Z is selected from O, C(O), CO 2 , S, SO 2 , SO, and NR 7 ; R 2 is H, R 3 is selected from H and C 1-6 alkyl, R 4 is selected from H, C 1-6 alkyl, C 6-18 aryl, C 1-16 alkyleneC 6-18 aryl, C 5-18 heteroaryl, and C 2-16 alkyleneC 5-18 heteroaryl; R 5 is selected from H, C 2-26 alkenyl, C 2-26 alkynyl, C 3-18 cycloalkyl, C 1-16 alkyleneC 3-18 cycloalkyl, C 2-16 alkenyleneC 3-18 cycloalkyl, C 2-16 alkynyleneC 3-18 cycloalkyl, C 3-18 heterocycloalkyl, C 1-16 alkyleneC 3-18 heterocycloalkyl, C 1-16 alkenyleneC 3-18 heterocycloalkyl, C 2-16 alkynyleneC 3-18 heterocycloalkyl, C 6-18 aryl, C 1-16 alkyleneC 6-18 aryl, C 2-16 alkenyleneC 6-18 aryl, C 2-16 alkynyleneC 6-18 aryl, C 5-18 heteroaryl, C 2-16 alkyleneC 5-18 heteroaryl, C 2-16 alkenyleneC 5-18 heteroaryl, C 2-16 alkynyleneC 5-18 heteroaryl, wherein all cycloalkyl, heterocycloalkyl, aryl and heteroaryl are optionally substituted with one or more substituents selected from OH, NO 2 , CN, halo, C 1-16 alkyl, C 2-16 alkenyl, C 2-16 alkynyl, OC 1-16 alkyl, OC 2-16 alkenyl, OC 2-16 alkynyl, C 1-16 alkyleneOR 9 C 2-16 alkenyleneOR 9 , C 2-16 alkynyleneOR 9 , SO 3 C 1-16 alkyl, SO 3 C 6-16 aryl, and SO 3 C 5-18 heteroaryl substituted with C 1-16 alkyl; or any two of R 2 , R 3 , R 4 and R 5 are linked together to form an unsubstituted or substituted monocyclic or polycyclic ring system having 4 or more atoms together with the carbon atoms to which said any two of R 2 , R 3 , R 4 and R 5 are bonded, wherein the monocyclic or polycyclic ring system is optionally substituted with one or more substituents selected ═O, OH, halo, C 1-16 alkyl, C 2-16 alkenyl, C 2-16 alkynyl, OC 1-16 alkyl, OC 2-16 alkenyl, OC 2-16 alkynyl; C 1-16 alkyleneOR 8 , C 2-16 alkenyleneOR 8 , C 2-16 alkynyleneOR 8 , C 6-18 aryl, C 3-18 cycloalkyl, C 3-18 heterocycloalkyl, and C 5-18 heteroaryl, the latter 4 groups being optionally substituted with one or more substituents selected from OH, halo, C 1-16 alkyl, OC 1-16 alkyl, and C 2-16 alkenyl; R 6 , R 7 , R 8 and R 9 are independently selected from H and C 1-6 alkyl; and all alkyl, alkenyl, alkynyl, alkylene, alkenylene, alkynylene, cycloalkyl, and heterocycloalkyl groups are optionally fluoro-substituted. 2. The process of claim 1 , wherein the non-protic solvent is a non-polar solvent or a polar aprotic solvent. 3. The process of claim 1 , wherein the aluminum compound is acidic alumina. 4. The process of claim 3 , wherein the process further comprises a dehydrating agent and/or an acid. 5. The process of claim 1 , wherein the polycyclic ring system is a gonanyl (steroid nucleus) which is optionally substituted with one or more substituents selected from OH, ═O, halo, C 1-16 alkyl, C 2-16 alkenyl, C 2-16 alkynyl, OC 1-16 alkyl, OC 2-16 alkenyl, OC 2-16 alkynyl, C 1-16 alkyleneOR 8 , C(O)C 1-16 alkyl, C(O)C 2-16 alkenyl, C(O)C 2-16 alkynyl, C 2-16 alkenyleneOR 8 , C 2-16 alkynyleneOR 8 , C 6-18 aryl, C 3-18 cycloalkyl, C 3-18 heterocycloalkyl, and C 5-18 heteroaryl, the latter 4 groups being optionally substituted with one or more substituents selected from OH, halo, C 1-16 alkyl, OC 1-16 alkyl, and C 2-16 alkenyl. 6. The process of claim 1 , wherein the polycyclic ring system is selected from benzofuranyl, isobenzofuranyl, indolyl, isoindolyl, quinolinyl, isoquinolinyl, benzepinyl, carbazolyl, and acridinyl which are optionally substituted with one or more substituents selected from OH, ═O, halo, C 1-16 alkyl, C 2-16 alkenyl, C 2-16 alkynyl, OC 1-16 alkyl, OC 2-16 alkenyl, OC 2-16 alkynyl, C(O)C 1-16 alkyl, C(O)C 2-16 alkenyl, C(O)C 2-16 alkynyl, C 1-16 alkyleneOR 8 , C 2-16 alkenyleneOR 8 , C 2-16 alkynyleneOR 8 , C 6-18 aryl, C 3-18 cycloalkyl, C 3-18 heterocycloalkyl, and C 5-18 heteroaryl, the latter 4 groups being optionally substituted with one or more substituents selected from OH, halo, C 1-16 alkyl, OC 1-16 alkyl, and C 2-16 alkenyl. 7. The process of claim 1 , wherein the polycyclic ring system is a benzofused ring system selected from benzofurochromenone, benzodiozinyl, benzodiozolyl, indenyl, indolinyl, chromenyl, dihydrochromenonyl, chromenonyl, chromanonyl, benzoxazinyl, quinolinonyl, isoquinolinonyl and coumarinyl which are optionally substituted with one or more substituents selected from OH, ═O, halo, C 1-16 alkyl, C 2-16 alkenyl, C 2-16 alkynyl, OC 1-16 alkyl, OC 2-16 alkenyl, OC 2-16 alkynyl, C 1-16 alkyleneOR 8 , C 2-16 alkenyleneOR 8 , C 2-16 alkynyleneOR 8 , C 6-18 aryl, C 3-18 cycloalkyl, C 3-18 heterocycloalkyl, and C 5-18 heteroaryl, the latter 4 groups being optionally substituted with one or more substituents selected from OH, halo, C 1-16 alkyl, OC 1-16 alkyl, and C 2-16 alkenyl. 8. The process of claim 1 ,

Assignees

Inventors

Classifications

  • C07C37/14Primary

    by addition reactions, i.e. reactions involving at least one carbon-to-carbon unsaturated bond · CPC title

  • Alumina · CPC title

  • by introduction of hydroxy or O-metal groups · CPC title

  • by reactions not involving the formation of nitro groups · CPC title

  • by reactions not involving the formation of cyano groups · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11795127B2 cover?
The present application describes process for preparing an ortho-allylated hydroxy aryl compounds such as compounds of Formula (I) by reacting an allylic alcohol with a hydroxy aryl compound in the presence of aluminum compound selected from alumina and aluminum alkoxides and in a non-protic solvent wherein at least one carbon atom ortho to the hydroxy group in the hydroxy aryl compound is unsu…
Who is the assignee on this patent?
Univ Mcmaster
What technology area does this patent fall under?
Primary CPC classification C07C37/14. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Oct 24 2023 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 2 related publications on this page (citations in our corpus or others sharing the same primary CPC).